Merck Grants $100k For Cardiac Cath Lab Program At RWJ Rahway

NJTODAY.NET's online business directory
Don Watson, Plant Manager, Merck & Co., Inc. Rahway-Linden site, and Larry Naldi, Senior Vice President Strategy and Integration, Merck & Co., Inc. tour RWJ Rahway’s Cardiac Catheterization Lab. Pictured are from back left: Don Watson, Marlene H. Lubinger, Foundation President, MaLu Hernandez, R.N, and from back right Larry Naldi, Helen Peare, R.N., B.S.N., Coordinator Ambulatory Cardiac Services and Kirk Tice, President & CEO, RWJ Rahway. (Photo courtesy of RWJ Rahway Foundation)

Don Watson, Plant Manager, Merck & Co., Inc. Rahway-Linden site, and Larry Naldi, Senior Vice President Strategy and Integration, Merck & Co., Inc. tour RWJ Rahway’s Cardiac Catheterization Lab. Pictured are from back left: Don Watson, Marlene H. Lubinger, Foundation President, MaLu Hernandez, R.N, and from back right Larry Naldi, Helen Peare, R.N., B.S.N., Coordinator Ambulatory Cardiac Services and Kirk Tice, President & CEO, RWJ Rahway. (Photo courtesy of RWJ Rahway Foundation)

RAHWAY — The Merck Company Foundation has provided funding for the training and staffing of registered nurses and radiology technologists for the newly renovated Cardiovascular Lab at RWJ Rahway. The $100K grant funded the training curriculum to provide best practice, technical knowledge, skills and the expertise necessary for outstanding outcomes in diagnostic cardiac catheterizations and emergency angioplasties.

According to Marlene Lubinger, president of the RWJ Rahway Foundation, almost one third of the people living in the hospital’s service area are 65 or older and that population is growing as the baby boomers age. Last year 62% of all patients admitted to the hospital were 65+ and more than half had a cardiac-related diagnosis. In addition, more than half of all patients admitted to the Emergency Center have a cardiac-related diagnosis.

“Understanding the need to provide cardiac caths and emergency angioplasties in a nearby and familiar setting for our patients and their families, the Hospital renovated and replaced the outdated Cardiac Cath Lab with a state-of-the-art Cath Lab” said Lubinger. In November the new lab with new capabilities opened with a new name…The Cardiovascular Lab at RWJ Rahway. In February, the new service, emergency angioplasty was added with the approval of the Department of Health and Senior Services. Dr. Michael Chen is the Medical Director Diagnostic Cath Lab and Dr. Ajay Agarwala is the Medical Director Interventional Cath Lab.

The Merck Company Foundation has been a long-time supporter of the hospital, and has partnered with RWJ Rahway on many initiatives including major renovations to the Emergency Department and the Cardiac Telemetry Unit.

In addition to The Merck Company Foundation, funding has been received from ConocoPhillips, E.J. Grassmann Trust, The Hyde and Watson Foundation, The Provident Bank Foundation, Standish Foundation and Union Foundation.


Connect with NJTODAY.NET


Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!
Email ads@njtoday.net for advertising information Send stuff to NJTODAY.NET Like Us On Facebook Follow Us On Twitter Download this week's issue of NJTODAY.NET

Leave a Reply